Probiotic intervention influences the salivary levels of Matrix Metalloproteinase (MMP)-9 and Tissue Inhibitor of metalloproteinases (TIMP)-1 in healthy adults

Archives of Oral Biology

Volumn 85, Issue , 2018, Pages 58-63

  Jäsberg, Heli ^a   Tervahartiala, Taina ^b   Sorsa, Timo ^b,c   Söderling, Eva ^a   Haukioja, Anna ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Bifidobacterium animalis subsp. lactis BB 12; Lactobacillus rhamnosus GG; Matrix metalloproteinase (MMP); Probiotic; Saliva; Tissue inhibitor of metalloproteinases (TIMP)

Indexed keywords

GELATINASE B; NEUTROPHIL COLLAGENASE; PROBIOTIC AGENT; TIMP1 PROTEIN, HUMAN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; BIFIDOBACTERIUM ANIMALIS; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LACTOBACILLUS RHAMNOSUS; MALE; METABOLISM; MICROBIOLOGY; NORMAL HUMAN; PERIODONTAL INDEX; PLAQUE INDEX; SALIVA;

ADULT; BIFIDOBACTERIUM ANIMALIS; DENTAL PLAQUE INDEX; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTHY VOLUNTEERS; HUMANS; LACTOBACILLUS RHAMNOSUS; MALE; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; PERIODONTAL INDEX; PROBIOTICS; SALIVA; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 85031038727     PISSN: 00039969     EISSN: 18791506     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2017.10.003     Document Type: Article

References (53)

1. Buduneli, E., Mäntylä, P., Emingil, G., Tervahartiala, T., Pussinen, P., Baris, N., et al. Acute myocardial infarction is reflected in salivary matrix metalloproteinase-8 activation level?. Journal of Periodontology 82:5 (2011), 716–725.
2. Cagetti, M., Mastroberardino, S., Milia, E., Cocco, F., Lingström, P., Campus, G., The use of probiotic strains in caries prevention: A systematic review. Nutrients 5:7 (2013), 2530–2550.
3. Caglar, E., Kuscu, O.O., Cildir, S.K., Kuvvetli, S.S., Sandalli, N., A probiotic lozenge administered medical device and its effect on salivary mutans streptococci and lactobacilli. International Journal of Paediatric Dentistry 18:1 (2008), 35–39.
4. Caglar, E., Topcuoglu, N., Cildir, S.K., Sandalli, N., Kulekci, G., Oral colonization by lactobacillus reuteri ATCC 55730 after exposure to probiotics. International Journal of Paediatric Dentistry 19:5 (2009), 377–381.
5. Devine, D., Marsh, P., Prospects for the development of probiotics and prebiotics for oral applications. Journal of Oral Microbiology, 1(1), 2009, 10.3402/jom.v1i0.1949.
6. Ebersole, J., Nagarajan, R., Akers, D., Miller, C., Targeted salivary biomarkers for discrimination of periodontal health and disease(s). Frontiers in Cellular and Infection Microbiology, 5, 2015, 62 [62].
7. Ericson, D., Hamberg, K., Bratthall, G., Sinkiewicz Enggren, G., Ljunggren, L., Salivary IgA response to probiotic bacteria and mutans streptococci after the use of chewing gum containing lactobacillus reuteri. Pathogens and Disease 68:3 (2013), 82–87.
8. Flichy Fernández, A.J., Ata Ali, J., Alegre Domingo, T., Candel Martí, E., Ata Ali, F., Palacio, J.R., et al. The effect of orally administered probiotic lactobacillus reuteri-containing tablets in peri-implant mucositis: A double-blind randomized controlled trial. Journal of Periodontal Research 50:6 (2015), 775–785.
9. Gürsoy, M., Könönen, E., Tervahartiala, T., Gürsoy, U.K., Pajukanta, R., Sorsa, T., Longitudinal study of salivary proteinases during pregnancy and postpartum. Journal of Periodontal Research 45:4 (2010), 496–503.
10. Gruner, D., Paris, S., Schwendicke, F., Probiotics for managing caries and periodontitis: Systematic review and meta-analysis. Journal of Dentistry 48 (2016), 16–25, 10.1016/j.jdent.2016.03.002.
11. Gueimonde, L., Vesterlund, S., García Pola, M., Gueimonde, M., Söderling, E., Salminen, S., Supplementation of xylitol-containing chewing gum with probiotics: A double blind, randomised pilot study focusing on saliva flow and saliva properties. Food & Function 7:3 (2016), 1601–1609.
12. Gursoy, U., Könönen, E., Pradhan Palikhe, P., Tervahartiala, T., Pussinen, P., Suominen Taipale, L., et al. Salivary MMP-8, TIMP-1, and ICTP as markers of advanced periodontitis. Journal of Clinical Periodontology 37:6 (2010), 487–493.
13. Hanemaaijer, R., Sorsa, T., Konttinen, Y.T., Ding, Y., Sutinen, M., Visser, H., et al. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. regulation by tumor necrosis factor-alpha and doxycycline. Journal of Biological Chemistry 272:50 (1997), 31504–31509.
14. Hatakka, K., Ahola, A.J., Yli Knuuttila, H., Richardson, M., Poussa, T., Meurman, J.H., et al. Probiotics reduce the prevalence of oral candida in the elderly–a randomized controlled trial. Journal of Dental Research 86:2 (2007), 125–130.
15. Haukioja, A., Loimaranta, V., Tenovuo, J., Probiotic bacteria affect the composition of salivary pellicle and streptococcal adhesion in vitro. Oral Microbiology and Immunology 23:4 (2008), 336–343.
16. Hedenbjörk Lager, A., Bjørndal, L., Gustafsson, A., Sorsa, T., Tjäderhane, L., Åkerman, S., et al. Caries correlates strongly to salivary levels of matrix metalloproteinase-8. Caries Research 49:1 (2015), 1–8.
17. Heikkinen, A., Nwhator, S., Rathnayake, N., Mäntylä, P., Vatanen, P., Sorsa, T., Pilot study on oral health status as assessed by an active matrix metalloproteinase-8 chairside mouthrinse test in adolescents. Journal of Periodontology 87:1 (2016), 36–40.
18. Hernández, M., Gamonal, J., Salo, T., Tervahartiala, T., Hukkanen, M., Tjäderhane, L., et al. Reduced expression of lipopolysaccharide-induced CXC chemokine in porphyromonas gingivalis-induced experimental periodontitis in matrix metalloproteinase-8 null mice. Journal of Periodontal Research 46:1 (2011), 58–66.
19. Ince, G., Gürsoy, H., Ipçi, S.D., Cakar, G., Emekli Alturfan, E., Yilmaz, S., Clinical and biochemical evaluation of lozenges containing lactobacillus reuteri as an adjunct to non-surgical periodontal therapy in chronic periodontitis. Journal of Periodontology 86:6 (2015), 746–754.
20. Iniesta, M., Herrera, D., Montero, E., Zurbriggen, M., Matos, A., Marín, M., et al. Probiotic effects of orally administered lactobacillus reuteri-containing tablets on the subgingival and salivary microbiota in patients with gingivitis. A randomized clinical trial. Journal of Clinical Periodontology 39:8 (2012), 736–744.
21. Jäsberg, H., Söderling, E., Endo, A., Beighton, D., Haukioja, A., Bifidobacteria inhibit the growth of porphyromonas gingivalis but not of streptococcus mutans in an in vitro biofilm model. European Journal of Oral Sciences 124:3 (2016), 251–258.
22. Jørgensen, M., Keller, M., Kragelund, C., Hamberg, K., Ericson, D., Nielsen, C., et al. Lactobacillus reuteri supplements do not affect salivary IgA or cytokine levels in healthy subjects: A randomized, double-blind, placebo-controlled, cross-over trial. Acta Odontologica Scandinavica 74:5 (2016), 399–404.
23. Klaenhammer, T., Kleerebezem, M., Kopp, M., Rescigno, M., The impact of probiotics and prebiotics on the immune system. Nature Reviews Immunology 12:10 (2012), 728–734.
24. Kotani, Y., Shinkai, S., Okamatsu, H., Toba, M., Ogawa, K., Yoshida, H., et al. Oral intake of lactobacillus pentosus strain b240 accelerates salivary immunoglobulin A secretion in the elderly: A randomized, placebo-controlled, double-blind trial. Immunity & Ageing, 7, 2010, 11 [11].
25. Kuula, H., Salo, T., Pirilä, E., Tuomainen, A., Jauhiainen, M., Uitto, V., et al. Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingivalis induced periodontitis. Infection and Immunity 77:2 (2009), 850–859.
26. Loe, H., Silness, J., Periodontal disease in pregnancy: I. prevalence and severity. Acta Odontologica Scandinavica 21 (1963), 533–551.
27. Martin Cabezas, R., Davideau, J., Tenenbaum, H., Huck, O., Clinical efficacy of probiotics as an adjunctive therapy to non-surgical periodontal treatment of chronic periodontitis: A systematic review and meta-analysis. Journal of Clinical Periodontology 43:6 (2016), 520–530.
28. Nedzi Góra, M., Kostrzewa Janicka, J., Górska, R., Elastase and metalloproteinase-9 concentrations in saliva in patients with chronic periodontitis, Central. European Journal of Immunology 39:3 (2014), 357–364.
29. Parks, W., Wilson, C., López Boado, Y., Matrix metalloproteinases as modulators of inflammation and innate immunity. Nature Reviews Immunology 4:8 (2004), 617–629.
30. Rathnayake, N., Akerman, S., Klinge, B., Lundegren, N., Jansson, H., Tryselius, Y., et al. Salivary biomarkers of oral health: A cross-sectional study. Journal of Clinical Periodontology 40:2 (2013), 140–147.
31. Reynolds, J.J., Collagenases and tissue inhibitors of metalloproteinases: A functional balance in tissue degradation. Oral Diseases 2:1 (1996), 70–76.
32. Saarinen, R., Pitkäranta, A., Kolho, K., Tervahartiala, T., Sorsa, T., Lauhio, A., Decreased salivary matrix metalloproteinase-8 reflecting a defensive potential in juvenile parotitis. International Journal of Pediatric Otorhinolaryngology 80 (2016), 74–77.
33. Saxelin, M., Lassig, A., Karjalainen, H., Tynkkynen, S., Surakka, A., Vapaatalo, H., et al. Persistence of probiotic strains in the gastrointestinal tract when administered as capsules, yoghurt, or cheese. International Journal of Food Microbiology 144:2 (2010), 293–300.
34. Silness, J., Loe, H., Periodontal disease in pregnancy: Ii. correlation between oral hygiene and periodontal condition. Acta Odontologica Scandinavica 22 (1964), 121–135.
35. Soell, M., Elkaim, R., Tenenbaum, H., Cathepsin C, matrix metalloproteinases, and their tissue inhibitors in gingiva and gingival crevicular fluid from periodontitis-affected patients. Journal of Dental Research 81:3 (2002), 174–178.
36. Sorsa, T., Tjäderhane, L., Salo, T., Matrix metalloproteinases (MMPs) in oral diseases. Oral Diseases 10:6 (2004), 311–318.
37. Sorsa, T., Gursoy, U., Nwhator, S., Hernandez, M., Tervahartiala, T., Leppilahti, J., et al. Analysis of matrix metalloproteinases, especially MMP-8, in gingival creviclular fluid, mouthrinse and saliva for monitoring periodontal diseases. Periodontology 2000 70:1 (2016), 142–163.
38. Staab, B., Eick, S., Knöfler, G., Jentsch, H., The influence of a probiotic milk drink on the development of gingivitis: A pilot study. Journal of Clinical Periodontology 36:10 (2009), 850–856.
39. Stamatova, I., Meurman, J., Kari, K., Tervahartiala, T., Sorsa, T., Baltadjieva, M., Safety issues of lactobacillus bulgaricus with respect to human gelatinases in vitro. FEMS Immunology and Medical Microbiology 51:1 (2007), 194–200.
40. Stecksén-Blicks, C., Sjöström, I., Twetman, S., Effect of long-term consumption of milk supplemented with probiotic lactobacilli and fluoride on dental caries and general health in preschool children: A cluster-randomized study. Caries Research 43:5 (2009), 374–381.
41. Surono, I., Koestomo, F., Novitasari, N., Zakaria, F., Yulianasari, Koesnandar, Novel probiotic enterococcus faecium IS-27526 supplementation increased total salivary sIgA level and bodyweight of pre-school children: A pilot study. Anaerobe 17:6 (2011), 496–500.
42. Szkaradkiewicz, A., Stopa, J., Karpinski, T., Effect of oral administration involving a probiotic strain of lactobacillus reuteri on pro-inflammatory cytokine response in patients with chronic periodontitis. Archivum Immunologiae Et Therapiae Experimentalis 62:6 (2014), 495–500.
43. Taipale, T., Pienihäkkinen, K., Salminen, S., Jokela, J., Söderling, E., Bifidobacterium animalis subsp. lactis BB-12 administration in early childhood: A randomized clinical trial of effects on oral colonization by mutans streptococci and the probiotic. Caries Research 46:1 (2012), 69–77.
44. Taipale, T., Pienihäkkinen, K., Alanen, P., Jokela, J., Söderling, E., Administration of bifidobacterium animalis subsp. lactis BB-12 in early childhood: A post-trial effect on caries occurrence at four years of age. Caries Research 47:5 (2013), 364–372.
45. Toiviainen, A., Jalasvuori, H., Lahti, E., Gursoy, U., Salminen, S., Fontana, M., et al. Impact of orally administered lozenges with lactobacillus rhamnosus GG and bifidobacterium animalis subsp. lactis BB-12 on the number of salivary mutans streptococci, amount of plaque, gingival inflammation and the oral microbiome in healthy adults. Clinical Oral Investigations 19:1 (2015), 77–83.
46. Twetman, S., Derawi, B., Keller, M., Ekstrand, K., Yucel Lindberg, T., Stecksen Blicks, C., Short-term effect of chewing gums containing probiotic lactobacillus reuteri on the levels of inflammatory mediators in gingival crevicular fluid. Acta Odontologica Scandinavica 67:1 (2009), 19–24.
47. Twetman, L., Larsen, U., Fiehn, N.E., Stecksén-Blicks, C., Twetman, S., Coaggregation between probiotic bacteria and caries-associated strains: An in vitro study?. Acta Odontologica Scandinavica 67:5 (2009), 284–288.
48. Verstappen, J., Von den Hoff, J.W., Tissue inhibitors of metalloproteinases (TIMPs): Their biological functions and involvement in oral disease. Journal of Dental Research 85:12 (2006), 1074–1084.
49. Vong, L., Lorentz, R., Assa, A., Glogauer, M., Sherman, P., Probiotic lactobacillus rhamnosus inhibits the formation of neutrophil extracellular traps. The Journal of Immunology 192:4 (2014), 1870–1877.
50. Vuotila, T., Ylikontiola, L., Sorsa, Luoto, T.H., Hanemaaijer, R., Salo, T., et al. The relationship between MMPs and pH in whole saliva of radiated head and neck cancer patients. Journal of Oral Pathology and Medicine 31:6 (2002), 329–338.
51. Wu, C., Chen, P., Lee, Y., Ko, J., Lue, K., Effects of immunomodulatory supplementation with lactobacillus rhamnosus on airway inflammation in a mouse asthma model. Journal of Microbiology Immunology and Infection 49:5 (2016), 625–635.
52. Yanine, N., Araya, I., Brignardello Petersen, R., Carrasco Labra, A., González, A., Preciado, A., et al. Effects of probiotics in periodontal diseases: A systematic review. Clinical Oral Investigations 17:7 (2013), 1627–1634.
53. Yli-Knuuttila, H., Snäll, J., Kari, K., Meurman, J.H., Colonization of lactobacillus rhamnosus GG in the oral cavity. Oral Microbiology and Immunology, 21(2), 2006, 129.